Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis

RTTNews | 935 gün önce
Stocktwits
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis

(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.

The LP-10 Phase 2a clinical trial was a multi-center, dose-escalation study, which recruited 13 subjects with moderate to severe refractory hemorrhagic cystitis. These subjects were treated with up to two courses of LP-10 intravesical bladder instillations.

The top line results indicated that all subjects tolerated LP-10 instillations and completed the study without report of product related serious adverse events. LP-10 pharmacokinetic analysis also demonstrated short duration of systemic uptake. There were also decreased hematuria, decreased cystoscopic bleeding and ulceration sites and improved patients' urinary symptoms.

Further, the responder analysis noted complete response in 3 subjects, partial response in 7 subjects and no response in 3 subjects.

As it next step, the company said it will communicate with the U.S. Food and Drug Administration (FDA) on the study's results and the pathway forward to seeking regulatory approval for LP-10. If approved, it will be a first-in class treatment for the cancer survivor community with hemorrhagic cystitis.

For More Such Health News, visit rttnews.com

Etiketler: LIPO
Stocktwits
read more
Taiwan Stock Market Tipped To Open Under Pressure On Monday

Taiwan Stock Market Tipped To Open Under Pressure On Monday

The Taiwan stock market on Friday snapped the two-day winning streak in which it had gained more than 340 points or 1.9 percent. The Taiwan Stock Exchange now sits just above the 23,430-point plateau and it's expected to see continued consolidation on Monday.
RTTNews | 16 dakika önce
Singapore Shares May Take Further Damage On Monday

Singapore Shares May Take Further Damage On Monday

The Singapore stock market had finished lower in six straight sessions, surrendering almost 120 points or 2.9 percent along the way. The Straits Times Index now sits just above the 4,150-point plateau and it's expected to open under pressure again on Monday.
RTTNews | 46 dakika önce
Malaysia Shares May Hand Back Friday's Gains

Malaysia Shares May Hand Back Friday's Gains

The Malaysia stock market has moved higher in two of three trading days since the end of the three-day losing streak in which it had fallen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just beneath the 1,535-point plateau although it may tick lower again on Monday.
RTTNews | 1s 16 dakika önce
Japan Stock Market May Extend Friday's Losses

Japan Stock Market May Extend Friday's Losses

The Japan stock market headed south again on Friday, one day after ending the four-day losing streak in which it had given up almost 1,175 points or 2.8 percent. The Nikkei 225 now sits just shy of the 40,800-point plateau and it may open to the downside again on Monday.
RTTNews | 1s 31 dakika önce
South Korea Shares May Extend Losing Streak

South Korea Shares May Extend Losing Streak

The South Korea stock market has moved lower in back-to-back sessions, tumbling more than 135 points or 3.9 percent along the way. The KOSPI now sits just shy of the 3,120-point plateau and it's likely to take further damage on Monday.
RTTNews | 1s 46 dakika önce
Japan Monetary Base Data Due On Monday

Japan Monetary Base Data Due On Monday

Japan will on Monday release July figures for monetary base, highlighting a very light day for Asia-Pacific economic activity. In June, the base was down 3.3 percent on year.
RTTNews | 2s 46 dakika önce
Araçlar
Ekonomik takvim
Piyasa saatleri
Faiz oranları
Tatil takvimi
Forex Piyasası
Forex Volatilitesi
Forex Korelasyonu
Forex Haberleri
forex analysis
COT Verisi
Likidite
Forex Hesaplayıcıları
Forex Isı Haritası
Gösterge ısı haritası
Topluluk
Topluluk
Sistemler
En Popüler Sistemler
Stratejiler
Yarışmalar
Forex Grafikleri
Forex Hassaslığı
Outlook İndikatörü
İncelemeler
Brokerlar
Prop Trading Firms
VPS Hizmetleri
Signal Sağlayıcılar
EA Programlama Servisleri
Affiliate Programs
PAMM Broker Servisleri
İndirim Programı Hizmetleri
Trading Platformları
Uzman Danışmanlar
Kripto Borsaları
Ticaret kursları
Brokerlar
Forex Spreadleri
Forex Broker Fiyatları
Forex Broker Swap’ları
Forex Broker Hacmi
Forex Broker Promosyonları Basın Bülteni
Platform
Widgetlar
Özellikler
API
RSS
Stock Portfolio
Affiliate Software
Gelişmiş Grafikler
Destek
Sıkça sorulan sorular
Yardım
Bizimle iletişime geç
Hata Bildir!
Hakkında
Blog
© 2025 Myfxbook Ltd. Her hakkı saklıdır.
YÜKSEK RİSK UYARI: Döviz trade’i, tüm yatırımcılar için uygun olmayabilecek yüksek düzeyde risk taşır. Kaldıraç, ek risk ve zarara maruz kalma yaratır. Döviz trade’i yapmaya karar vermeden önce yatırım hedeflerinizi, deneyim seviyenizi ve risk toleransınızı dikkatlice değerlendirin. İlk yatırımınızın bir kısmını veya tamamını kaybedebilirsiniz. Kaybetmeyi göze alamayacağınız parayla yatırım yapmayın. Döviz trade’i ile ilgili riskler konusunda kendinizi eğitin ve herhangi bir sorunuz varsa bağımsız bir finans veya vergi danışmanından tavsiye alın. Her türlü veri ve bilgi 'olduğu gibi' yalnızca bilgilendirme amaçlıdır ve trading amaçları veya tavsiye amaçlı değildir. Geçmiş performans gelecekteki sonuçların göstergesi değildir.